“To B or Not to B”…That Is the Question: Whether We Can Identify Those at Risk for Cardiac Dysfunction During Cancer Therapy

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)1033-1034
Number of pages2
JournalJACC: Heart Failure
Volume6
Issue number12
DOIs
StatePublished - Dec 2018

Keywords

  • anthracycline
  • cardiotoxicity
  • heart failure stages
  • trastuzumab

Cite this